A consortium of academic partners is inviting applications from highly motivated candidates for postdoctoral positions at the Experimental and Population-based Pathogen Investigation center (EPPIcenter) at UC San Francisco, Johns Hopkins Bloomberg School of Public Health, or a possible secondment at Imperial College. Ideal candidates with have experience with modeling and/or genomic analysis and will study the transmission of malaria and apply genomic use cases using data from a large malaria genomic epidemiology project in southern Africa. Successful candidates will have the option to be based at one of the three institutions in alignment with research interests and benefit from a rich and interdisciplinary research environment, working closely with Drs. Bryan Greenhouse (UCSF), Amy Wesolowski (JHBSPH) and Robert Verity (Imperial) as well as a diverse and international team of collaborators.

The fellow(s) will be expected to develop, optimize, and apply statistical and/or mathematical models using genetic, spatial, and epidemiologic data in order to further methods and implementation of malaria genomic use cases in southern Africa. These use cases include connectivity and importation as well as more established cases around drug and diagnostic resistance. Fellows will also work directly with regional and in-country partners and have a role to develop capacity and support a wide array of publications using these data. Our team is directly involved in all aspects of data generation and analysis including study design, supporting generation of laboratory data, methods development, modeling, communicating directly with malaria control programs and policy makers. The project is strongly focused on building research and technical capacity with local partners.
To Apply:

Send a CV including publications, brief statement of research/career interests, and contact information for up to 3 references to Tiese Estim-Inyang (Tiese.Etim-Inyang@ucsf.edu).

Applications will be evaluated on a rolling basis with a final deadline of January 15th, 2023.